TIDMGWP
RNS Number : 4133H
GW Pharmaceuticals PLC
17 August 2016
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 18 FEBRUARY 2016 TO: 17 AUGUST 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
42,400 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
17,000 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
25,400 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
200,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
200,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
122,613 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
301,779,915 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 18 FEBRUARY 2016 TO: 17 AUGUST 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
144,737 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
0 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
144,737 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
500,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
800,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JANUARY 2015
500,000 ORDINARY SHARES OF 0.1P EACH ON 5 JUNE 2015
741,558 ORDINARY SHARES OF 0.1P EACH ON 8 SEPTEMBER 2015
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
301,779,915 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 18 FEBRUARY 2016 TO: 17 AUGUST 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
200,250 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
0 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
200,250 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008
400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010
400,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
168,650 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
301,779,915 ORDINARY SHARES OF 0.1P EACH
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS LONG TERM INCENTIVE PLAN 2008
3. PERIOD OF RETURN:
FROM: 18 FEBRUARY 2016 TO: 17 AUGUST 2016
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
647,071 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING
PERIOD:
497,229 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF
PERIOD:
1,149,842 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT
SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
600,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
1,000,000 ORDINARY SHARES OF 0.1P EACH ON 5 JUNE 2015
758,442 ORDINARY SHARES OF 0.1P EACH ON 8 SEPTEMBER 2015
1,000,000 ORDINARY SHARES OF 0.1P EACH ON 18 MARCH 2016
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE
PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
301,779,915 ORDINARY SHARES OF 0.1P EACH
For further information, please contact:
Adam George, Company Secretary, GW Pharmaceuticals plc
Telephone: +44 (0)1223 266800
James Steel/Oliver Jackson, Nominated Adviser, Peel Hunt LLP
Telephone: +44 (0)20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRGRGDIUUBBGLR
(END) Dow Jones Newswires
August 17, 2016 03:56 ET (07:56 GMT)
Gw Pharmaceuticals (LSE:GWP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Gw Pharmaceuticals (LSE:GWP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
